Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
The funds will be used for general corporate purposes, with a focus on reducing operating expenses and exploring strategic alternatives for MAT2203, the Company’s Phase 3-ready antifungal drug ...
10 family-friendly U.S. vacations, from the mountains to the beach
Looking for a multi-generational getaway this year? These destinations strike the right balance between price and comfort, ...